Cancer Cachexia Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Cancer Cachexia Market is segmented By Drug (Anabolic Steroids, Anti-inflammatory Drugs), By Route of Administration (Oral, Parenteral), By Disease Stage (Early-stage Cachexia, Late-stage Cachexia), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.
Cancer Cachexia Market Size
Market Size in USD
CAGR6.4%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 6.4% |
| Market Concentration | High |
| Major Players | Helsinn Therapeutics, Actimed Therapeutics, Pfizer, Aveo Oncology, Artelo Biosciences |
please let us know !
Cancer Cachexia Market Analysis
The cancer cachexia market is estimated to be valued at USD 2.66 Bn in 2024 and is expected to reach USD 4.11 Bn by 2031, growing at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031. Rising awareness among patients and healthcare professionals regarding management of cancer related weight loss is expected to boost the demand. Moreover, development and commercialization of novel drugs and therapies for cachexia indication will further support the market growth through 2031.